Castellano, Elena http://orcid.org/0000-0001-6622-4267
,
Attanasio, R.
Giagulli, V. A.
Boriano, A.
Terzolo, M.
Papini, E.
Guastamacchia, E.
Monti, S.
Aglialoro, A.
Agrimi, D.
Ansaldi, E.
Babini, A. C.
Blatto, A.
Brancato, D.
Casile, C.
Cassibba, S.
Crescenti, C.
De Feo, M. L.
Del Prete, A.
Disoteo, O.
Ermetici, F.
Fiore, V.
Fusco, A.
Gioia, D.
Grassi, A.
Gullo, D.
Lo Pomo, F.
Miceli, A.
Nizzoli, M.
Pellegrino, M.
Pirali, B.
Santini, C.
Settembrini, S.
Tortato, E.
Triggiani, V.
Vacirca, A.
Borretta, G.
Article History
Received: 30 July 2018
Accepted: 24 September 2018
First Online: 1 October 2018
Change Date: 17 December 2018
Change Type: Correction
Change Details: The article [The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen], written by [Elena Castellano, R. Attanasio, V. A. Giagulli, A. Boriano, M. Terzolo, E. Papini, E. Guastamacchia, S. Monti, A. Aglialoro, D. Agrimi, E. Ansaldi, A. C. Babini, A. Blatto, D. Brancato].
Compliance with ethical standards
:
: C.E., A.R., B.A., T.M., P.E., G.E., B. A.C., B.A., B.D., C.C., D.F.M.L., D.P.A.,E.F., F.A., G.D., L.P. F., M.A., N.M., P.B., P.M., S.C., T.E., T.V., V.A. and B.G. have nothing to disclose. G.V.A. has participated in advisory panels for Bayer. A.D. has participated in advisory panels for Novartis. C.S. has received research support from Eli-Lilly. D.O. has received research support from Boehringer, Eli-Lilly,Merck Serono, Novartis, Novo Nordisk,Takeda. G.D. is consultant for Boehringer, Sanofi, Takeda. F.V. has received research support from Astra-Zeneca, Eli-Lilly, Novo Nordisk, Bayer, Novartis and Merck Serono. S.S. is on the speakers’ bureau for Boehringer-Ingelheim, Astra-Zeneca, Eli-Lilly,Takeda and Sanofi-Aventis.